Peripheral Neuropathy

Peripheral Neuropathy (PN) results from damage to the nerves of the Peripheral Nervous System (PNS). The PNS comprises all of the nerves outside of the brain and spinal cord. PN most commonly affects the extremities–hands and feet.

PN causes different sensations in the affected areas. Generally speaking, peripheral neuropathy will cause varying degrees of numbness in the extremities, ranging from a tingling sensation to a lack of sensation.

There are over 100 types of Peripheral Neuropathies. They are categorized based on the type of nerve affected, the area of the body affected, and the symptoms experienced by the patient. It is estimated that up to 20% of cancer patients will develop some type of PN during treatment.

Causes

PN is not exclusive to lymphoma patients or cancer patients; there are myriad causes ranging from diabetes to thyroid disorders. In lymphoma patients, the damage is usually caused by either chemotherapy or radiation. Once the drug therapy is finished, the PN usually dissipates.

The following chemotherapy agents are well known causes of PN:

Common Symptoms

Some patients experience pain while others experience numbness. Uncontrollable twitching, muscle weakness, and constipation are also symptoms.

Also, tumors may swell near nerves, causing temporary damage. If this is the case, symptoms may persist until the tumors have shrunk from treatment.

Peripheral Neuropathy as a result of cancer treatments is often temporary and patients recover quickly. If you suffer from PN for an extended period of time and symptoms do not disappear, alert your doctor (Late Effects). Medications used to treat epilepsy and depression have been known to help ease symptoms. Your doctor will know the best options for you.

Resources

Related Articles

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap